Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vitamin D receptor gene polymorphisms and prostate cancer risk.

The Prostate - 1 Jun 2004

Cheteri Mahesh B Keitheri, Stanford Janet L, Friedrichsen Danielle M, Peters Mette A, Iwasaki Lori, Langlois Mariela C, Feng Ziding, Ostrander Elaine A

Abstract excerpt

BACKGROUND: Vitamin D is a steroid hormone that is thought to play a role in the etiology and progression of prostate cancer. Hormone activity requires binding to the vitamin D receptor (VDR), which contains several genetic polymorphisms that have been associated with risk of prostate cancer. To...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genetic Predisposition to Disease
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Incidence

Share to Polymorphism, Genetic

Share to Prostatic Neoplasms

Share to Receptors, Calcitriol

Share to Risk Factors

Source

Identifiers

PMID: 15065089
DOI: 10.1002/pros.20001

Genes

VDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15065089-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vitamin D receptor gene polymorphisms and prostate cancer risk.PMID 15065089Read ↗

Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Lack of association between vitamin D receptor gene FokI and BsmI polymorphisms and prostate cancer risk: an updated meta-analysis involving 21,756 subjects.Semantic proximity Read ↗

Vitamin D receptor genotypes/haplotypes and prostate cancer risk.Semantic proximity Read ↗

Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.Semantic proximity Read ↗

Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.Semantic proximity Read ↗

Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population.Semantic proximity Read ↗

Vitamin D receptor polymorphisms and prostate cancer.Semantic proximity Read ↗

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.Semantic proximity Read ↗

Association of VDR polymorphisms ( Taq I and Bsm I) with prostate cancer: a new meta-analysis.Semantic proximity Read ↗

Genetic polymorphisms of vitamin D receptor and the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.